Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.6700
-0.0400 (-5.63%)
At close: Aug 25, 2026
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 47.06 million as of August 27, 2026. Its market cap has decreased by -13.22% in one year.
Market Cap
47.06M
Enterprise Value
35.57M
Revenue
21.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.67
ChartMarket Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 47.06M, a decrease of -80.02%. That is a compound annual growth rate of -28.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 47.06M | 6.26% |
| Dec 30, 2025 | 44.29M | 81.07% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| QBNK Holding AB | 71.67M |
| Beyond Frames Entertainment AB | 59.63M |
| Mendole | 58.92M |
| Touchtech AB | 53.65M |
| Redsense Medical AB | 53.12M |
| OurLiving AB | 47.36M |
| Kontigo Care AB | 46.71M |
| Lightning Group AB | 43.85M |